Clinical Trial Update: Evaluation of the Immunogenicity and Safety of VARIVAX™ in Healthy Russians (V210-058) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating immunogenicity and safety of VARIVAX in healthy Russian participants has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Varicella

Drugs mentioned

• Varivax (varicella vaccine (live attenuated))

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Varicella | Phase 3 | Status: COMPLETED | Results posted: 2021-04-06